Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma((R))) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System.

Copyright © Ark Medical Solutions Inc. All Rights Reserved.